Skip to main content
Swedish Orphan Biovitrum AB (publ) (BIOVF)
OTCMKTS · Delayed Price · Currency is USD
28.71
0.00 (0.00%)
At close: Mar 20, 2025

BIOVF Revenue

In the year 2024, Swedish Orphan Biovitrum AB had annual revenue of 26.03B SEK with 17.65% growth. Swedish Orphan Biovitrum AB had revenue of 7.44B in the quarter ending December 31, 2024, with 8.67% growth.

Revenue
26.03B SEK
Revenue Growth
+17.65%
P/S Ratio
n/a
Revenue / Employee
14.15M SEK
Employees
1,840
Market Cap
9.83B USD

Revenue Chart

* This company reports financials in SEK.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202426.03B3.90B17.65%
Dec 31, 202322.12B3.33B17.74%
Dec 31, 202218.79B3.26B21.00%
Dec 31, 202115.53B268.00M1.76%
Dec 31, 202015.26B1.01B7.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
SS Innovations International 16.04M
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Glass House Brands 200.90M
Northwest Biotherapeutics 1.60M
Silence Therapeutics 43.26M
American Oncology Network 1.76B
Revenue Rankings

Swedish Orphan Biovitrum AB News

More News